1. Al-Nakib, W., Higgins, P.G., Barrow, G.I., Tyrrell, D.A.J., Andries, K., Vanden Bussche, G. Taylor, N. and Janssen, P.A.J. (1989) Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837) Antimicrob Agents Chemother., 33,522-5.
2. Al-Nakib, W.. Higgins, P.G., Barrow, I., Tyrrell D.A.J., Lenox-Smith I. and Ishitsuka, H. (1987) Intranasal chalcone Ro 09-0410 as prophylaxis against rhinovirus infection in human volunteers. J. Antimicrob. Chemother., 20, 887 - 92.
3. Al-Nakib, W., Willman, J., Higgins, P.G., Tyrrell, D.A.J., Shepherd, W.M. and Freestone, D.S. (1987) Failure of intranasally administered 4', 6-dichloroflavan to protect against rhinovirus infection in man. Arch. Virol, 92, 255 - 60.
4. Andries, K., Dewindt, B., Brabander, M., Stokbroekx, R. and Janssen, P.A.J. (1988) In vitro activity of R61837, a new antirhinovirus compound. Arch. Virol, 101, 155 - 67.
5. Arden, N.H., Patriarca, P.A., Fasano, M.B., Lui, K.J., Harmon, M.W., Kendal. A.P. and Rimland, D. (1988) The roles of vaccination and amantadine prophylaxis in controlling a outbreak of influenza A (H3N2) in a nursing home. Arch. Intern. Med., 148, 865 - 8.